| Identifier | Return Reference | Explanation |
|---|---|---|
| CONTINUATION OF SUMMARY OF DIRECT CHARITABLE ACTIVITIES DESCRIPTION | FORM 990-PF, PART VIII-A SUMMARY OF DIRECT CHARITABLE ACTIVITIES | PURPOSE OF ORGANIZATION - REPEAT OF STATEMENT 15THE A. F. ROTHSCHILD FUND IS A PRIVATE OPERATING FOUNDATION DEDICATED TO THE WELL- BEING OF HORSES AND OTHER EQUINES. THE FUND DIRECTLY ENGAGES IN INITIATION, DEVELOPMENT, AND IMPLEMENTATION OF EQUINE-SPECIFIC SCIENTIFIC RESEARCH, TECHNOLOGICAL INNOVATIONS, ACADEMIC SCHOLARSHIP, AND RELATED EDUCATIONAL PROJECTS THROUGH PROGRAM INITIATIVES OF THE CENTER FOR CONTEMPORARY EQUINE STUDIES (CCES), A SUPPORTING ORGANIZATION HEADQUARTERED IN WOODSIDE,CA.THE FOUNDATION'S TWO PRINCIPLE DIRECT ACTIVITIES DURING 2021 WERE:RESEARCH - CONTINUED FROM STATEMENT 16CONTINUATION OF A MULTI-YEAR RESEARCH COLLABORATION WITH THE PETA INTERNATIONAL SCIENCE CONSORTIUM (PISC) TO ADVANCE DEVELOPMENT OF MODERN RECOMBINANT ANTIBODY REPLACEMENTS FOR ARCHAIC EQUINE-DERIVED THERAPEUTIC ANTITOXINS, ANTIVENOMS, AND OTHER SCIENTIFICALLY & ETHICALLY OBSOLETE HORSE SERUM PRODUCTS THROUGH USE OF THE PHAGE DISPLAY METHOD AS AN IN VITRO BIOTECHNOLOGY FOR GENERATION OF ANTIBODIES AGAINST BACTERIAL, VIRAL AND EUKARYOTIC PATHOGENS, AS WELL AS MICROBIAL TOXINS, INTENDED FOR DIAGNOSTIC APPLICATIONS AND THERAPEUTIC USE IN HUMANS.DURING THE CURRENT TAX YEAR THE THIRD MILESTONE IN DEVELOPMENT OF A RECOMBINANT ALTERNATIVE TO EQUINE-DERIVED BLACK WIDOW ANTIVENOM WAS ACCOMPLISHED, COMPLETING THE CHARACTERIZATION AND SEQUENCING OF UP TO 15 PURIFIED ANTI-BLACK WIDOW TOXIN ANTIBODIES IN SCFV PHAGE FORMAT.PROJECT COMPLETION AND PUBLICATION OF THE FINAL RESULTS IS TENTATIVELY PROJECTED FOR 2022.CF., ROTH, K., WENZEL, E. V., ET AL. (2021) "DEVELOPING RECOMBINANT ANTIBODIES BY PHAGE DISPLAY AGAINST INFECTIOUS DISEASES AND TOXINS FOR DIAGNOSTICS AND THERAPY." FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 11, 697876.EDUCATION - CONTINUED FROM STATEMENT 17EDUCATION, INCLUDING CONFERENCE PRESENTATIONS, PUBLICATIONS AND LECTURES:IN NOVEMBER 2020 THE FOUNDATION ISSUED A FORMAL REQUEST FOR ACADEMIC PROPOSALS TO PROMOTE SCHOLARSHIP ON THE HISTORICAL AND PRESENT INDUSTRIAL USE OF HORSES AND OTHER EQUINES AS "TRADITIONAL" LIVING SOURCES OF HUMAN PHARMACEUTICAL PRODUCTS. THE FINAL PROPOSAL APPROVED FOR FUNDING DURING 2021 WAS SUBMITTED BY A HIGHLY QUALIFIED BRAZILIAN SCHOLAR, MARKING THE FOUNDATION'S FIRST DIRECT ACTIVITY PERFORMED BY AN INDIVIDUAL OUTSIDE THE U.S. FOR ADVANCEMENT OF THE FOUNDATION'S EDUCATIONAL PURPOSE AND SUCCESSFULLY RESULTED IN ACHIEVING THE FOLLOWING GOALS:I. CONFERENCE PRESENTATIONS"PRELIMINARY NOTES FOR A HISTORY OF EQUINE SERUM PRODUCTION IN BRAZIL" IN EQUINE ECOLOGIES & ECONOMIES." ANNUAL EQUINE HISTORY COLLECTIVE CONFERENCE (CONVENED ONLINE). MARCH 25, 2021."THE USE OF HORSES IN ANTIBODY PRODUCTION: AN EQUINE HISTORY OF MODERN MEDICINE." EQUINE CULTURES IN TRANSITION CONFERENCE, SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES. UPPSALA, SWEDEN. JUNE 22, 2021."HISTORY, DEVELOPMENT AND PERSPECTIVES ON THE USE OF HORSES FOR SERUM PRODUCTION IN BRAZIL." PANEL ON HORSES AND HUMAN HEALTH, 5TH MEETING OF THE ANTHROPOLOGY OF HEALTH. SEPTEMBER 24, 2021. (A VIDEO OF THE PRESENTATION IS PENDING FINAL EDITING FOR ONLINE PUBLICATION IN 2022.)"POISONED HORSES: A HISTORY OF THE USE OF EQUINES FOR ANTIVENOM PRODUCTION IN 20TH CENTURY BRAZIL." SUBMITTED FOR PRESENTATION AT THE CONFERENCE OF THE EUROPEAN SOCIETY OF ENVIRONMENTAL HISTORY. SCHEDULED FOR JUNE 2022.II. PUBLICATIONSCAMPHORA, A.L. AND PUCCA, M. (2021) "HORSES USED FOR LARGE-SCALE PRODUCTION OF IMMUNOGLOBULINS: AN INTER-SPECIES APPROACH." INTERNATIONAL ANIMAL HEALTH JOURNAL VOL 9 ISSUE 4: 12-16.CAMPHORA, A.L. "HISTORY, DEVELOPMENT AND CURRENT ETHICAL CONSIDERATIONS ON THE USE OF EQUINES FOR PLASMA PRODUCTION IN BRAZIL." IN REINS, HALTERS AND CENTAURS: EQUESTRIAN CULTURES AND OTHER HUMAN-EQUINE RELATIONS IN BRAZIL." ADELMAN, CAMPHORA, ANDPEREIRA (EDITORS).PENDING COMPLETION FOR PUBLICATION BY WHITE HORSE PRESS (UK) IN 2022.III. LECTURES NOTES FOR A MODERN AND CONTEMPORARY HISTORY OF THE USE OF HORSES FOR PLASMA PRODUCTION IN BRAZIL." THREE-HOUR LECTURE PRESENTED IN PORTUGUESE FOR POST- GRADUATE PROGRAM IN THE HEALTH SCIENCES, FEDERAL UNIVERSITY OF RORAIMA, BRAZIL. JULY 12, 2021IV. WORK IN PROGRESS"HISTORIES ACROSS SPECIES," ARCADIA, A JOURNAL OF THE RACHEL CARSON CENTER AND THE EUROPEAN SOCIETY OF ENVIRONMENTAL HISTORY. PENDING REVIEW FOR ONLINE PUBLICATION IN 2022.NOTE ON EXPENSES FOR CHARITABLE PURPOSES PAID IN YEAR:THE FOUNDATION HAS ESTABLISHED AND FOLLOWS PROCEDURES FOR MONITORING FUNDING TO QUALIFIED INDIVIDUALS OUTSIDE THE UNITED STATES:ALL SPONSORED RESEARCH AND EDUCATIONAL PROGRAMS, BOTH WITHIN AND OUTSIDE THE U.S., ARE CONDUCTED AS DIRECT ACTIVITIES OF THE FOUNDATION UNDER SUPERVISION OF THE PRESIDENT IN CONSULTATION WITH THE FOUNDATION'S SCIENTIFIC ADVISOR(S) AND OTHER EXPERTS SPECIALIZING IN THE RELEVANT FIELDS OF KNOWLEDGE. GOALS AND MILESTONES ARE DOCUMENTED IN A FORMAL WRITTEN AGREEMENT AND PROGRESS IS CLOSELY MONITORED THROUGH MONTHLY REPORTS AND BI-MONTHLY ONLINE MEETINGS AS PREREQUISITE FOR CONTINUED FUNDING, INCLUDING SUBMISSION OF A COMPREHENSIVE FINAL REPORT PROVIDING A NARRATIVE SUMMARY OF ACCOMPLISHMENTS, ITEMIZED DETAILS OF RESEARCH ACTIVITIES, AND THE RESULTING CONFERENCE PRESENTATIONS, SEMINARS, WHITE PAPERS, AND PEER-REVIEW PUBLICATIONS. |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| TIME WARNER ENTMT CO DUE 3/15/2023 | 29,347 | 27,088 |
| FORD MOTOR COMPANY DUE 8/1/2026 | 29,228 | 29,324 |
| APPLE INC AT 3.35% DUE 2/9/2027 | 25,534 | 27,120 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 360 SHS APPLE INC | 9,531 | 63,925 |
| 330 SHS CISCO SYS INC | 9,884 | 20,912 |
| 100 SHS CME GROUP INC | 10,167 | 22,846 |
| 160 SHS MERCK & CO INC | 9,495 | 12,262 |
| 75 SHS TRAVELERS COMPANIES INC | 8,705 | 11,732 |
| 130 SHS VISA INC | 10,198 | 28,172 |
| 100 SHS WALT DISNEY CO | 10,042 | 15,489 |
| 400 SHS SCHWAB US MID CAP ETF | 17,360 | 32,172 |
| 260 SH COMCAST CORP | 10,053 | 13,086 |
| 220 SHS NVIDIA CORP | 8,763 | 64,704 |
| 80 SH RESMED INC | 7,956 | 20,838 |
| 160 SH VERIZON COMMUNICATIONS | 9,110 | 8,314 |
| 105 SH ZOETIS INC. | 14,958 | 25,623 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES/ DUES | 99 | 0 | 99 | 0 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| DIVIDENDS IN TRANSIT AT YEAR END | 22 | 38 | 38 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FUNDED RESEARCH | 6,795 | 0 | 0 | 6,795 |
| SUBSCRIPTION | 12 | 0 | 12 | 0 |
| POSTAGE | 14 | 0 | 14 | 0 |
| ANNUAL DOMAIN NAME REGISTRATION | 48 | 0 | 48 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| CLASS ACTION SETTLEMENT - SECURITIES | 39 | 39 | 39 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT MANGEMENT FEES | 2,944 | 2,944 | 2,944 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ILLINOIS FILING FEES | 100 | 0 | 100 | 0 |
| FEDERAL TAXES | 89 | 0 | 0 | 0 |